Literature DB >> 20885354

Ghrelin in diseases of the gastric mucosa associated with Helicobacter pylori infection.

Anna Zub-Pokrowiecka1, Kazimierz Rembiasz, Stanislaw J Konturek, Andrzej Budzynski, Peter C Konturek, Piotr Budzynski.   

Abstract

BACKGROUND: Ghrelin is a hormone produced by neuroendocrine cells of gastric mucosa. Its concentration changes in cases of Helicobacter pylori (H. pylori) infection of stomach, but the relation between the expression of plasma and mucosal ghrelin content and H. pylori infection is not completely defined. This study was designed to determine the changes in plasma and gastric mucosa ghrelin concentrations in diseases of gastric mucosa depending upon the H. pylori infection. MATERIAL/
METHODS: The following groups were included; Group 1. patients with gastric cancer and concomitant H. pylori infection (N=25); Group 2. patients with antral gastritis with H. pylori infection and concomitant duodenal peptic ulcer (N=18); Group 3. patients with atrophic gastritis of both the fundus and the body of the stomach without H. pylori infection (N=10); Group 4. control group consisting of patients without morphological and histological lesions of gastric mucosa and without H. pylori infection (n=25). Endoscopic biopsies of gastric mucosa of fundus, body and pyloric region were obtained in all tested groups. In patients suffering from gastric cancer biopsies of tumor were also taken. The ghrelin concentrations were measured by specific RIA. Biopsy specimens were examined to assess ghrelin mRNA expression in intact gastric mucosa and gastric cancer.
RESULTS: The study showed significant influence of H. pylori infection on ghrelin plasma concentrations. The highest ghrelin concentrations were found in patients of the group 2 (average 503 pg/mL (95% CI: 285-886). Ghrelin concentrations were found to fall to the lowest values in the group 3 (average 144 pg/mL (95% CI: 93-222). In the group 1, the ghrelin concentration averaged 203 pg/mL (95% CI: 161-257), while in the group 4 (control group) - 255 pg/mL; 95% (CI: 160-406). The study proved that gastric cancer does not exert any ghrelin-production activity, as confirmed by RT-PCR examination of biopsy specimens of the cancer.
CONCLUSIONS: This study shows that the presence of H. pylori in the stomach with peptic ulcer increases plasma ghrelin levels, whereas in gastric cancer and atrophic gastritis it is accompanied by a marked decrease in plasma and cancer tissue levels of ghrelin.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20885354

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  12 in total

1.  Ghrelin and gastrin in advanced gastric cancer before and after gastrectomy.

Authors:  Anna Zub-Pokrowiecka; Kazimierz Rembiasz; Peter C Konturek; Andrzej Budzyński; Stanisław J Konturek; Marek Winiarski; Władysław Bielański
Journal:  World J Gastroenterol       Date:  2011-01-28       Impact factor: 5.742

Review 2.  Impairment of ghrelin synthesis in Helicobacter pylori-colonized stomach: new clues for the pathogenesis of H. pylori-related gastric inflammation.

Authors:  Omero Alessandro Paoluzi; Del Vecchio Giovanna Blanco; Roberta Caruso; Ivan Monteleone; Giovanni Monteleone; Francesco Pallone
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

3.  Clinical significance of ghrelin expression in the gastric mucosa of morbidly obese patients.

Authors:  Yasuhiro Miyazaki; Shuji Takiguchi; Yosuke Seki; Kazunori Kasama; Tsuyoshi Takahashi; Yukinori Kurokawa; Makoto Yamasaki; Hiroshi Miyata; Kiyokazu Nakajima; Masaki Mori; Yuichiro Doki
Journal:  World J Surg       Date:  2013-12       Impact factor: 3.352

Review 4.  Brain-gut axis in the pathogenesis of Helicobacter pylori infection.

Authors:  Jacek Budzyński; Maria Kłopocka
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

5.  Administration of obestatin accelerates the healing of chronic gastric ulcers in rats.

Authors:  Artur Dembiński; Zygmunt Warzecha; Piotr Ceranowicz; Jakub Cieszkowski; Marcin Dembiński; Agata Ptak-Belowska; Atsukasu Kuwahara; Ikuo Kato
Journal:  Med Sci Monit       Date:  2011-08

6.  Ghrelin accelerates the healing of cysteamine-induced duodenal ulcers in rats.

Authors:  Zygmunt Warzecha; Dagmara Ceranowicz; Artur Dembiński; Piotr Ceranowicz; Jakub Cieszkowski; Atsukazu Kuwahara; Ikuo Kato; Marcin Dembiński; Peter C Konturek
Journal:  Med Sci Monit       Date:  2012-05

Review 7.  Helicobacter pylori infection and circulating ghrelin levels - a systematic review.

Authors:  Chidi V Nweneka; Andrew M Prentice
Journal:  BMC Gastroenterol       Date:  2011-01-26       Impact factor: 3.067

Review 8.  Is there an effect of ghrelin/ghrelin analogs on cancer? A systematic review.

Authors:  Sakine Sever; Donna L White; José M Garcia
Journal:  Endocr Relat Cancer       Date:  2016-09       Impact factor: 5.678

9.  Serum ghrelin; a new surrogate marker of gastric mucosal alterations in upper gastrointestinal carcinogenesis.

Authors:  Alireza Sadjadi; Abbas Yazdanbod; Yeong Yeh Lee; Majid Boreiri; Fatemeh Samadi; Behrooz Z Alizadeh; Farhad Islami; Valerie Fyfe; Masoud Babaei; Mohammad J Namazi; James J Going; Masoud Sotoudeh; Geertruida H de Bock; Reza Malekzadeh; Mohammad H Derakhshan
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

10.  Ghrelin as a possible biomarker and maintaining factor in patients with eating disorders reporting childhood traumatic experiences.

Authors:  Eleonora Rossi; Emanuele Cassioli; Veronica Gironi; Eglantina Idrizaj; Rachele Garella; Roberta Squecco; Maria Caterina Baccari; Mario Maggi; Linda Vignozzi; Paolo Comeglio; Valdo Ricca; Giovanni Castellini
Journal:  Eur Eat Disord Rev       Date:  2021-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.